ARCHIVES

FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment.

This article is from The Cancer Letter archive.

Vol. 39 No. 45 | December 17, 2013

Download PDF Visit The Full Archive

Related Articles

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978

NCI Initiatives: Advisors Approves AIDS, Minority Training Programs

December 13, 1996

IOM: No Negligence In FIAU Clinical Trial That Killed Five

March 31, 1995

Also AACI honors MIT’s Robert Weinberg. Bernard Fisher wins two awards.

November 21, 2003

Funding Opportunities: NCI’s RAPID Program; RFA, Pas Avilable

May 14, 1999

Mammary Cell/Hormone Report Abstracts From BCTF Meeting

January 16, 1976